A Review on the Role of Mitochondrial DNA Mutations in Cancer
Archives of Medical Laboratory Sciences,
Vol. 7 (2021),
13 March 2021
,
Page 1-12 (e18)
https://doi.org/10.22037/amls.v7.34736
Abstract
Mitochondria implement various cellular functions, including energy production through the electron transport chain by oxidative phosphorylation mechanism. These respiratory chains consist of several complexes and protein subunits which are encoded by nuclear and mitochondrial genes. Due to mutation susceptibility and repair limitation, more aberrations have occurred in mitochondrial DNA in comparison to nuclear DNA. Given the fact that mitochondrial DNA lacks introns, mutations almost occur in the coding sequence, which comprises a direct impact on its functions.
Emerging evidence indicates that mutations in the mitochondrial DNA led to the production of reactive oxygen species, disrupted apoptosis, and tumor development. Studies reported various somatic and germline variants in mitochondrial DNA related to tumorigenesis. The D-loop region which is the starting point for replication and transcription of mitochondrial DNA is the most prevalent site of somatic mutations in solid tumors. The D-loop mutations also cause copy number variations which are gaining interest in studies of solid tumors including breast cancer, colon cancer, hepatocellular carcinomas, and prostate cancer. Most studies have reported a mitochondrial DNA reduction which subsequently prevents apoptosis and promotes metastasis. The mitochondrial DNA region-specific haplogroups are also involved in the sequence variations due to processes such as genetic drift and adaptive selection.
This review article discusses the biology and function of mitochondria and related genes. By explanation of mitochondrial dysfunction caused by different kinds of alterations, we attempt to elucidate the role of mitochondria in tumorigenesis. Prominently published articles in this field were reviewed and the role of germline and somatic mutations of mitochondrial DNA have been investigated in common cancers.
*Corresponding Author: Shirin Shahbazi; Email: sh.shahbazi@modares.ac.ir; ORCID iD: 0000-0002-7634-5350
Please cite this article as: Dahi F, Mortezanejad S, Nakhaee S, Geranpayeh L, Shahbazi S. A Review on the Role of Mitochondrial DNA Mutations in Cancer. Arch Med Lab Sci. 2021;7:1-12 (e18). https://doi.org/10.22037/amls.v7.34736
- Mitochondria
- mtDNA Copy Number
- Tumorigenesis
- Polymorphisms
How to Cite
References
Wallace DC. Mitochondrial DNA mutations in disease and aging. Environmental and Molecular Mutagenesis. 2010;51(5):440-50.
Chandra D, Singh KK. Genetic insights into OXPHOS defect and its role i1. Wallace DC. Mitochondrial DNA mutations in disease and aging. Environmental and Molecular Mutagenesis. 2010;51(5):440-50.
Chandra D, Singh KK. Genetic insights into OXPHOS defect and its role in cancer. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 2011;1807(6):620-5.
Ju YS, Alexandrov LB, Gerstung M, Martincorena I, Nik-Zainal S, Ramakrishna M, et al. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer. eLife. 2014;3.
Stewart JB, Alaei-Mahabadi B, Sabarinathan R, Samuelsson T, Gorodkin J, Gustafsson CM, et al. Simultaneous DNA and RNA Mapping of Somatic Mitochondrial Mutations across Diverse Human Cancers. PLoS genetics. 2015;11(6):e1005333.
Kaipparettu BA, Ma Y, Park JH, Lee TL, Zhang Y, Yotnda P, et al. Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways. PloS one. 2013;8(5):e61747.
Kühlbrandt W. Structure and function of mitochondrial membrane protein complexes. BMC Biology. 2015;13(1):89.
Chiang SC, Meagher M, Kassouf N, Hafezparast M, McKinnon PJ, Haywood R, et al. Mitochondrial protein-linked DNA breaks perturb mitochondrial gene transcription and trigger free radical-induced DNA damage. Science advances. 2017;3(4):e1602506.
Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nature reviews Genetics. 2012;13(12):878-90.
Imanishi H, Hattori K, Wada R, Ishikawa K, Fukuda S, Takenaga K, et al. Mitochondrial DNA mutations regulate metastasis of human breast cancer cells. PloS one. 2011;6(8):e23401.
Pfleger J, He M, Abdellatif M. Mitochondrial complex II is a source of the reserve respiratory capacity that is regulated by metabolic sensors and promotes cell survival. Cell Death & Disease. 2015;6(7):e1835-e.
Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science (New York, NY). 1989;246(4930):629-34.
Kalen AL, Ahmad IM, Abdalla MY, O’Malley YQ, Goswami PC, Sarsour EH. MnSOD and Cyclin B1 Coordinate a Mito-Checkpoint during Cell Cycle Response to Oxidative Stress. Antioxidants. 2017;6(4):92.
Kulawiec M, Ayyasamy V, Singh KK. p53 regulates mtDNA copy number and mitocheckpoint pathway. Journal of carcinogenesis. 2009;8:8.
Nagano H, Hashimoto N, Nakayama A, Suzuki S, Miyabayashi Y, Yamato A, et al. p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells. Proceedings of the National Academy of Sciences. 2018;115(33):8370-5.
Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290(5806):457-65.
Kang I, Chu CT, Kaufman BA. The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms. FEBS letters. 2018;592(5):793-811.
Kunkel GH, Chaturvedi P, Tyagi SC. Mitochondrial pathways to cardiac recovery: TFAM. Heart failure reviews. 2016;21(5):499-517.
D'Souza AR, Minczuk M. Mitochondrial transcription and translation: overview. Essays in biochemistry. 2018;62(3):309-20.
Jemt E, Persson Ö, Shi Y, Mehmedovic M, Uhler JP, Dávila López M, et al. Regulation of DNA replication at the end of the mitochondrial D-loop involves the helicase TWINKLE and a conserved sequence element. Nucleic Acids Research. 2015;43(19):9262-75.
Mercer TR, Neph S, Dinger ME, Crawford J, Smith MA, Shearwood AM, et al. The human mitochondrial transcriptome. Cell. 2011;146(4):645-58.
Williams SB, Ye Y, Huang M, Chang DW, Kamat AM, Pu X, et al. Mitochondrial DNA Content as Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms. Cancer prevention research (Philadelphia, Pa). 2015;8(7):607-13.
Lightowlers RN, Chinnery PF, Turnbull DM, Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends in genetics : TIG. 1997;13(11):450-5.
Stewart JB, Chinnery PF. The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease. Nature Reviews Genetics. 2015;16(9):530-42.
Floros VI, Pyle A, Dietmann S, Wei W, Tang WCW, Irie N, et al. Segregation of mitochondrial DNA heteroplasmy through a developmental genetic bottleneck in human embryos. Nature Cell Biology. 2018;20(2):144-51.
Beadnell TC, Scheid AD, Vivian CJ, Welch DR. Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer. Cancer metastasis reviews. 2018;37(4):615-32.
Chatterjee A, Mambo E, Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene. 2006;25(34):4663-74.
Yuan Y, Ju YS, Kim Y, Li J, Wang Y, Yoon CJ, et al. Comprehensive molecular characterization of mitochondrial genomes in human cancers. Nature Genetics. 2020;52(3):342-52.
Tan DJ, Bai RK, Wong LJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer research. 2002;62(4):972-6.
Weissensteiner H, Pacher D, Kloss-Brandstätter A, Forer L, Specht G, Bandelt HJ, et al. HaploGrep 2: mitochondrial haplogroup classification in the era of high-throughput sequencing. Nucleic Acids Res. 2016;44(W1):W58-63.
Quintana-Murci L, Semino O, Bandelt H-J, Passarino G, McElreavey K, Santachiara-Benerecetti AS. Genetic evidence of an early exit of Homo sapiens sapiens from Africa through eastern Africa. Nature Genetics. 1999;23(4):437-41.
Loogväli EL, Roostalu U, Malyarchuk BA, Derenko MV, Kivisild T, Metspalu E, et al. Disuniting uniformity: a pied cladistic canvas of mtDNA haplogroup H in Eurasia. Molecular biology and evolution. 2004;21(11):2012-21.
Reznik E, Miller ML, Şenbabaoğlu Y, Riaz N, Sarungbam J, Tickoo SK, et al. Mitochondrial DNA copy number variation across human cancers. eLife. 2016;5.
Hu L, Yao X, Shen Y. Altered mitochondrial DNA copy number contributes to human cancer risk: evidence from an updated meta-analysis. Scientific Reports. 2016;6(1):35859.
Kalsbeek AMF, Chan EKF, Corcoran NM, Hovens CM, Hayes VM. Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management. Oncotarget. 2017;8(41):71342-57.
Lemnrau A, Brook MN, Fletcher O, Coulson P, Tomczyk K, Jones M, et al. Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Breast Cancer. Cancer research. 2015;75(14):2844-50.
Achanta G, Sasaki R, Feng L, Carew JS, Lu W, Pelicano H, et al. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. The EMBO journal. 2005;24(19):3482-92.
Sun W, Qin X, Zhou J, Xu M, Lyu Z, Li X, et al. Mitochondrial DNA copy number in cervical exfoliated cells and risk of cervical cancer among HPV-positive women. BMC Women's Health. 2020;20(1):139.
Tanaka T, Kobunai T, Yamamoto Y, Murono K, Otani K, Yasuda K, et al. Increased Copy Number Variation of mtDNA in an Array-based Digital PCR Assay Predicts Ulcerative Colitis-associated Colorectal Cancer. In vivo (Athens, Greece). 2017;31(4):713-8.
Patel TH, Norman L, Chang S, Abedi S, Liu C, Chwa M, et al. European mtDNA Variants Are Associated With Differential Responses to Cisplatin, an Anticancer Drug: Implications for Drug Resistance and Side Effects. Frontiers in oncology. 2019;9:640.
Shahbazi S, Alavi S, Majidzadeh AK, Ghaffarpour M, Soleimani A, Mahdian R. BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Medical oncology (Northwood, London, England). 2013;30(1):393.
Mohamadalizadeh-Hanjani Z, Shahbazi S, Geranpayeh L. Investigation of the SPAG5 gene expression and amplification related to the NuMA mRNA levels in breast ductal carcinoma. World Journal of Surgical Oncology. 2020;18(1):225.
Tseng LM, Yin PH, Chi CW, Hsu CY, Wu CW, Lee LM, et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes, chromosomes & cancer. 2006;45(7):629-38.
Zhu W, Qin W, Sauter ER. Large-scale mitochondrial DNA deletion mutations and nuclear genome instability in human breast cancer. Cancer Detect Prev. 2004;28(2):119-26.
Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer research. 2001;61(20):7623-6.
Canter JA, Kallianpur AR, Parl FF, Millikan RC. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer research. 2005;65(17):8028-33.
Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer letters. 2007;249(2):249-55.
Grzybowska-Szatkowska L, Slaska B. Mitochondrial NADH dehydrogenase polymorphisms are associated with breast cancer in Poland. Journal of applied genetics. 2014;55(2):173-81.
Pezzotti A, Kraft P, Hankinson SE, Hunter DJ, Buring J, Cox DG. The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk. PloS one. 2009;4(4):e5356.
Jiang H, Zhao H, Xu H, Hu L, Wang W, Wei Y, et al. Peripheral blood mitochondrial DNA content, A10398G polymorphism, and risk of breast cancer in a Han Chinese population. Cancer science. 2014;105(6):639-45.
Behroozi J, Shahbazi S, Bakhtiarizadeh MR, Mahmoodzadeh H. ADAR expression and copy number variation in patients with advanced gastric cancer. BMC gastroenterology. 2020;20(1):152.
Hiyama T, Tanaka S, Shima H, Kose K, Tuncel H, Ito M, et al. Somatic mutation in mitochondrial DNA and nuclear microsatellite instability in gastric cancer. Oncology reports. 2003;10(6):1837-41.
Burgart LJ, Zheng J, Shu Q, Strickler JG, Shibata D. Somatic mitochondrial mutation in gastric cancer. The American journal of pathology. 1995;147(4):1105-11.
Wang H, Wang Y, Zhao Q, Guo Z, Zhang F, Zhao Y, et al. Identification of sequence polymorphisms in the D-Loop region of mitochondrial DNA as a risk factor for gastric cancer. Mitochondrial DNA Part A, DNA mapping, sequencing, and analysis. 2016;27(2):1045-7.
Liao LM, Baccarelli A, Shu XO, Gao YT, Ji BT, Yang G, et al. Mitochondrial DNA copy number and risk of gastric cancer: a report from the Shanghai Women's Health Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011;20(9):1944-9.
Zhang G, Qu Y, Dang S, Yang Q, Shi B, Hou P. Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients. Diagnostic pathology. 2013;8:173.
Zhu X, Mao Y, Huang T, Yan C, Yu F, Du J, et al. High mitochondrial DNA copy number was associated with an increased gastric cancer risk in a Chinese population. Molecular carcinogenesis. 2017;56(12):2593-600.
Er LM, Li Y, Er L, Wu M, Zheng XL, Guo ZJ, et al. Associations between Single Nucleotide Polymorphisms in the Mitochondrial DNA D-Loop Region and Outcome of Gastroenteropancreatic Neuroendocrine Neoplasm. Annals of clinical and laboratory science. 2018;48(3):333-7.
Er LM, Wu ML, Gao Y, Wang SJ, Li Y. Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for gastroenteropancreatic neuroendocrine neoplasm. Journal of clinical laboratory analysis. 2017;31(5).
Jin EH, Sung JK, Lee SI, Hong JH. Mitochondrial NADH Dehydrogenase Subunit 3 (MTND3) Polymorphisms are Associated with Gastric Cancer Susceptibility. International journal of medical sciences. 2018;15(12):1329-33.
Wang C, Wang Y, Wang H, Zhang R, Guo Z. Mitochondrial DNA haplogroup N is associated good outcome of gastric cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35(12):12555-9.
Shahbazi S, Khorasani M, Mahdian R. Gene expression profile of FVII and AR in primary prostate cancer. Cancer biomarkers : section A of Disease markers. 2016;17(3):353-8.
Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(3):719-24.
Kloss-Brandstätter A, Schäfer G, Erhart G, Hüttenhofer A, Coassin S, Seifarth C, et al. Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. American journal of human genetics. 2010;87(6):802-12.
Koochekpour S, Marlowe T, Singh KK, Attwood K, Chandra D. Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men. PloS one. 2013;8(9):e74688.
Tu H, Gu J, Meng QH, Kim J, Davis JW, He Y, et al. Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer. Oncotarget. 2015;6(39):41988-96.
Hopkins JF, Sabelnykova VY, Weischenfeldt J, Simon R, Aguiar JA, Alkallas R, et al. Mitochondrial mutations drive prostate cancer aggression. Nature Communications. 2017;8(1):656.
Schöpf B, Weissensteiner H, Schäfer G, Fazzini F, Charoentong P, Naschberger A, et al. OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation. Nature Communications. 2020;11(1):1487.
Akouchekian M, Houshmand M, Hemati S, Ansaripour M, Shafa M. High rate of mutation in mitochondrial DNA displacement loop region in human colorectal cancer. Diseases of the colon and rectum. 2009;52(3):526-30.
Akouchekian M, Houshmand M, Akbari MH, Kamalidehghan B, Dehghan M. Analysis of mitochondrial ND1 gene in human colorectal cancer. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. 2011;16(1):50-5.
Theodoratou E, Din FV, Farrington SM, Cetnarskyj R, Barnetson RA, Porteous ME, et al. Association between common mtDNA variants and all-cause or colorectal cancer mortality. Carcinogenesis. 2010;31(2):296-301.
Guo Z, Zhao S, Fan H, Du Y, Zhao Y, Wang G. Identification of sequence polymorphisms in the D-Loop region of mitochondrial DNA as a risk factor for colon cancer. Mitochondrial DNA Part A, DNA mapping, sequencing, and analysis. 2016;27(6):4244-5.
Wallace L, Mehrabi S, Bacanamwo M, Yao X, Aikhionbare FO. Expression of mitochondrial genes MT-ND1, MT-ND6, MT-CYB, MT-COI, MT-ATP6, and 12S/MT-RNR1 in colorectal adenopolyps. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016;37(9):12465-75.
Govatati S, Saradamma B, Malempati S, Dasi D, Thupurani MK, Nagesh N, et al. Association of mitochondrial displacement loop polymorphisms with risk of colorectal cancer in south Indian population. Mitochondrial DNA Part A, DNA mapping, sequencing, and analysis. 2017;28(5):632-7.
Thyagarajan B, Guan W, Fedirko V, Barcelo H, Ramasubramaian R, Gross M, et al. Associations of mitochondrial polymorphisms with sporadic colorectal adenoma. Molecular carcinogenesis. 2018;57(5):598-605.
Wen S, Gao J, Zhang L, Zhou H, Fang D, Feng S. p53 increase mitochondrial copy number via up-regulation of mitochondrial transcription factor A in colorectal cancer. Oncotarget. 2016;7(46).
Horton TM, Petros JA, Heddi A, Shoffner J, Kaufman AE, Graham SD, Jr., et al. Novel mitochondrial DNA deletion found in a renal cell carcinoma. Genes, chromosomes & cancer. 1996;15(2):95-101.
Xu J, Guo Z, Zhang J, Cui L, Zhang S, Bai Y. Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of renal cell carcinoma. Sci Rep. 2013;3:2408.
Zhang J, Guo Z, Bai Y, Cui L, Zhang S, Xu J. Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for renal cell carcinoma. Biomedical reports. 2013;1(4):563-6.
Bai Y, Guo Z, Xu J, Liu S, Zhang J, Cui L, et al. Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with renal cell carcinoma outcome. Mitochondrial DNA. 2015;26(2):224-6.
Bai Y, Guo Z, Xu J, Zhang J, Cui L, Zhang H, et al. The 9-bp deletion at position 8272 in region V of mitochondrial DNA is associated with renal cell carcinoma outcome. Mitochondrial DNA Part A, DNA mapping, sequencing, and analysis. 2016;27(3):1973-5.
Purdue MP, Hofmann JN, Colt JS, Hoxha M, Ruterbusch JJ, Davis FG, et al. A case-control study of peripheral blood mitochondrial DNA copy number and risk of renal cell carcinoma. PloS one. 2012;7(8):e43149.
Hofmann JN, Hosgood HD, 3rd, Liu CS, Chow WH, Shuch B, Cheng WL, et al. A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Carcinogenesis. 2014;35(5):1028-31.
Wang Z, Choi S, Lee J, Huang YT, Chen F, Zhao Y, et al. Mitochondrial Variations in Non-Small Cell Lung Cancer (NSCLC) Survival. Cancer informatics. 2015;14(Suppl 1):1-9.
Ding C, Li R, Wang P, Jin P, Li S, Guo Z. Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for lung cancer. Mitochondrial DNA. 2012;23(4):251-4.
Chen J, Zhang L, Yu X, Zhou H, Luo Y, Wang W, et al. Clinical application of plasma mitochondrial DNA content in patients with lung cancer. Oncology letters. 2018;16(6):7074-81.
Kazdal D, Harms A, Endris V, Penzel R, Kriegsmann M, Eichhorn F, et al. Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancer. British Journal of Cancer. 2017;117(2):220-6.
Lin CS, Lee MC, Hsu JC, Pan SC, Wei YH. AB001. Low mitochondrial DNA copy number is associated with low mitochondrial DNA integrity and advanced T-status in non-small cell lung cancer. Journal of Thoracic Disease. 2017;9(Suppl 14).
n cancer. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 2011;1807(6):620-5.
Ju YS, Alexandrov LB, Gerstung M, Martincorena I, Nik-Zainal S, Ramakrishna M, et al. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer. eLife. 2014;3.
Stewart JB, Alaei-Mahabadi B, Sabarinathan R, Samuelsson T, Gorodkin J, Gustafsson CM, et al. Simultaneous DNA and RNA Mapping of Somatic Mitochondrial Mutations across Diverse Human Cancers. PLoS genetics. 2015;11(6):e1005333.
Kaipparettu BA, Ma Y, Park JH, Lee TL, Zhang Y, Yotnda P, et al. Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways. PloS one. 2013;8(5):e61747.
Carew JS, Huang P. Mitochondrial defects in cancer. Molecular Cancer. 2002;1(1):9.
Kühlbrandt W. Structure and function of mitochondrial membrane protein complexes. BMC Biology. 2015;13(1):89.
Chiang SC, Meagher M, Kassouf N, Hafezparast M, McKinnon PJ, Haywood R, et al. Mitochondrial protein-linked DNA breaks perturb mitochondrial gene transcription and trigger free radical-induced DNA damage. Science advances. 2017;3(4):e1602506.
Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nature reviews Genetics. 2012;13(12):878-90.
Imanishi H, Hattori K, Wada R, Ishikawa K, Fukuda S, Takenaga K, et al. Mitochondrial DNA mutations regulate metastasis of human breast cancer cells. PloS one. 2011;6(8):e23401.
Pfleger J, He M, Abdellatif M. Mitochondrial complex II is a source of the reserve respiratory capacity that is regulated by metabolic sensors and promotes cell survival. Cell Death & Disease. 2015;6(7):e1835-e.
Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science (New York, NY). 1989;246(4930):629-34.
Kulawiec M, Ayyasamy V, Singh KK. p53 regulates mtDNA copy number and mitocheckpoint pathway. Journal of carcinogenesis. 2009;8:8.
Park CB, Larsson NG. Mitochondrial DNA mutations in disease and aging. The Journal of cell biology. 2011;193(5):809-18.
Holland MM, Parsons TJ. Mitochondrial DNA Sequence Analysis - Validation and Use for Forensic Casework. Forensic science review. 1999;11(1):21-50.
Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290(5806):457-65.
Kang I, Chu CT, Kaufman BA. The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms. FEBS letters. 2018;592(5):793-811.
Kunkel GH, Chaturvedi P, Tyagi SC. Mitochondrial pathways to cardiac recovery: TFAM. Heart failure reviews. 2016;21(5):499-517.
D'Souza AR, Minczuk M. Mitochondrial transcription and translation: overview. Essays in biochemistry. 2018;62(3):309-20.
Uchida A, Murugesapillai D, Kastner M, Wang Y, Lodeiro MF, Prabhakar S, et al. Unexpected sequences and structures of mtDNA required for efficient transcription from the first heavy-strand promoter. eLife. 2017;6.
Taanman J-W. The mitochondrial genome: structure, transcription, translation and replication. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1999;1410(2):103-23.
Holzmann J, Frank P, Löffler E, Bennett KL, Gerner C, Rossmanith W. RNase P without RNA: identification and functional reconstitution of the human mitochondrial tRNA processing enzyme. Cell. 2008;135(3):462-74.
Mercer TR, Neph S, Dinger ME, Crawford J, Smith MA, Shearwood AM, et al. The human mitochondrial transcriptome. Cell. 2011;146(4):645-58.
Jemt E, Persson Ö, Shi Y, Mehmedovic M, Uhler JP, Dávila López M, et al. Regulation of DNA replication at the end of the mitochondrial D-loop involves the helicase TWINKLE and a conserved sequence element. Nucleic Acids Research. 2015;43(19):9262-75.
Williams SB, Ye Y, Huang M, Chang DW, Kamat AM, Pu X, et al. Mitochondrial DNA Content as Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms. Cancer prevention research (Philadelphia, Pa). 2015;8(7):607-13.
Lightowlers RN, Chinnery PF, Turnbull DM, Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends in genetics : TIG. 1997;13(11):450-5.
Stewart JB, Chinnery PF. The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease. Nature Reviews Genetics. 2015;16(9):530-42.
Floros VI, Pyle A, Dietmann S, Wei W, Tang WCW, Irie N, et al. Segregation of mitochondrial DNA heteroplasmy through a developmental genetic bottleneck in human embryos. Nature Cell Biology. 2018;20(2):144-51.
Beadnell TC, Scheid AD, Vivian CJ, Welch DR. Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer. Cancer metastasis reviews. 2018;37(4):615-32.
Chatterjee A, Mambo E, Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene. 2006;25(34):4663-74.
Yuan Y, Ju YS, Kim Y, Li J, Wang Y, Yoon CJ, et al. Comprehensive molecular characterization of mitochondrial genomes in human cancers. Nature Genetics. 2020;52(3):342-52.
Tan DJ, Bai RK, Wong LJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer research. 2002;62(4):972-6.
Weissensteiner H, Pacher D, Kloss-Brandstätter A, Forer L, Specht G, Bandelt HJ, et al. HaploGrep 2: mitochondrial haplogroup classification in the era of high-throughput sequencing. Nucleic Acids Res. 2016;44(W1):W58-63.
Quintana-Murci L, Semino O, Bandelt H-J, Passarino G, McElreavey K, Santachiara-Benerecetti AS. Genetic evidence of an early exit of Homo sapiens sapiens from Africa through eastern Africa. Nature Genetics. 1999;23(4):437-41.
Loogväli EL, Roostalu U, Malyarchuk BA, Derenko MV, Kivisild T, Metspalu E, et al. Disuniting uniformity: a pied cladistic canvas of mtDNA haplogroup H in Eurasia. Molecular biology and evolution. 2004;21(11):2012-21.
Reznik E, Miller ML, Şenbabaoğlu Y, Riaz N, Sarungbam J, Tickoo SK, et al. Mitochondrial DNA copy number variation across human cancers. eLife. 2016;5.
Hu L, Yao X, Shen Y. Altered mitochondrial DNA copy number contributes to human cancer risk: evidence from an updated meta-analysis. Scientific Reports. 2016;6(1):35859.
Kalsbeek AMF, Chan EKF, Corcoran NM, Hovens CM, Hayes VM. Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management. Oncotarget. 2017;8(41):71342-57.
Lemnrau A, Brook MN, Fletcher O, Coulson P, Tomczyk K, Jones M, et al. Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Breast Cancer. Cancer research. 2015;75(14):2844-50.
Achanta G, Sasaki R, Feng L, Carew JS, Lu W, Pelicano H, et al. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. The EMBO journal. 2005;24(19):3482-92.
Tanaka M, Ozawa T. Strand asymmetry in human mitochondrial DNA mutations. Genomics. 1994;22(2):327-35.
Shahbazi S, Alavi S, Majidzadeh AK, Ghaffarpour M, Soleimani A, Mahdian R. BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Medical oncology (Northwood, London, England). 2013;30(1):393.
Mohamadalizadeh-Hanjani Z, Shahbazi S, Geranpayeh L. Investigation of the SPAG5 gene expression and amplification related to the NuMA mRNA levels in breast ductal carcinoma. World Journal of Surgical Oncology. 2020;18(1):225.
Tseng LM, Yin PH, Chi CW, Hsu CY, Wu CW, Lee LM, et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes, chromosomes & cancer. 2006;45(7):629-38.
Zhu W, Qin W, Sauter ER. Large-scale mitochondrial DNA deletion mutations and nuclear genome instability in human breast cancer. Cancer Detect Prev. 2004;28(2):119-26.
Tseng L-M, Yin P-H, Chi C-W, Hsu C-Y, Wu C-W, Lee L-M, et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes, chromosomes & cancer. 2006;45(7):629-38.
Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer research. 2001;61(20):7623-6.
Canter JA, Kallianpur AR, Parl FF, Millikan RC. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer research. 2005;65(17):8028-33.
Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer letters. 2007;249(2):249-55.
Grzybowska-Szatkowska L, Slaska B. Mitochondrial NADH dehydrogenase polymorphisms are associated with breast cancer in Poland. Journal of applied genetics. 2014;55(2):173-81.
Pezzotti A, Kraft P, Hankinson SE, Hunter DJ, Buring J, Cox DG. The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk. PloS one. 2009;4(4):e5356.
Jiang H, Zhao H, Xu H, Hu L, Wang W, Wei Y, et al. Peripheral blood mitochondrial DNA content, A10398G polymorphism, and risk of breast cancer in a Han Chinese population. Cancer science. 2014;105(6):639-45.
Behroozi J, Shahbazi S, Bakhtiarizadeh MR, Mahmoodzadeh H. ADAR expression and copy number variation in patients with advanced gastric cancer. BMC gastroenterology. 2020;20(1):152.
Hiyama T, Tanaka S, Shima H, Kose K, Tuncel H, Ito M, et al. Somatic mutation in mitochondrial DNA and nuclear microsatellite instability in gastric cancer. Oncology reports. 2003;10(6):1837-41.
Burgart LJ, Zheng J, Shu Q, Strickler JG, Shibata D. Somatic mitochondrial mutation in gastric cancer. The American journal of pathology. 1995;147(4):1105-11.
Wang H, Wang Y, Zhao Q, Guo Z, Zhang F, Zhao Y, et al. Identification of sequence polymorphisms in the D-Loop region of mitochondrial DNA as a risk factor for gastric cancer. Mitochondrial DNA Part A, DNA mapping, sequencing, and analysis. 2016;27(2):1045-7.
Liao LM, Baccarelli A, Shu XO, Gao YT, Ji BT, Yang G, et al. Mitochondrial DNA copy number and risk of gastric cancer: a report from the Shanghai Women's Health Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011;20(9):1944-9.
Zhang G, Qu Y, Dang S, Yang Q, Shi B, Hou P. Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients. Diagnostic pathology. 2013;8:173.
Zhu X, Mao Y, Huang T, Yan C, Yu F, Du J, et al. High mitochondrial DNA copy number was associated with an increased gastric cancer risk in a Chinese population. Molecular carcinogenesis. 2017;56(12):2593-600.
Er LM, Li Y, Er L, Wu M, Zheng XL, Guo ZJ, et al. Associations between Single Nucleotide Polymorphisms in the Mitochondrial DNA D-Loop Region and Outcome of Gastroenteropancreatic Neuroendocrine Neoplasm. Annals of clinical and laboratory science. 2018;48(3):333-7.
Er LM, Wu ML, Gao Y, Wang SJ, Li Y. Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for gastroenteropancreatic neuroendocrine neoplasm. Journal of clinical laboratory analysis. 2017;31(5).
Jin EH, Sung JK, Lee SI, Hong JH. Mitochondrial NADH Dehydrogenase Subunit 3 (MTND3) Polymorphisms are Associated with Gastric Cancer Susceptibility. International journal of medical sciences. 2018;15(12):1329-33.
Wang C, Wang Y, Wang H, Zhang R, Guo Z. Mitochondrial DNA haplogroup N is associated good outcome of gastric cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35(12):12555-9.
Shahbazi S, Khorasani M, Mahdian R. Gene expression profile of FVII and AR in primary prostate cancer. Cancer biomarkers : section A of Disease markers. 2016;17(3):353-8.
Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(3):719-24.
Kloss-Brandstätter A, Schäfer G, Erhart G, Hüttenhofer A, Coassin S, Seifarth C, et al. Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. American journal of human genetics. 2010;87(6):802-12.
Koochekpour S, Marlowe T, Singh KK, Attwood K, Chandra D. Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men. PloS one. 2013;8(9):e74688.
Tu H, Gu J, Meng QH, Kim J, Davis JW, He Y, et al. Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer. Oncotarget. 2015;6(39):41988-96.
Hopkins JF, Sabelnykova VY, Weischenfeldt J, Simon R, Aguiar JA, Alkallas R, et al. Mitochondrial mutations drive prostate cancer aggression. Nature Communications. 2017;8(1):656.
Schöpf B, Weissensteiner H, Schäfer G, Fazzini F, Charoentong P, Naschberger A, et al. OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation. Nature Communications. 2020;11(1):1487.
Akouchekian M, Houshmand M, Hemati S, Ansaripour M, Shafa M. High rate of mutation in mitochondrial DNA displacement loop region in human colorectal cancer. Diseases of the colon and rectum. 2009;52(3):526-30.
Akouchekian M, Houshmand M, Akbari MH, Kamalidehghan B, Dehghan M. Analysis of mitochondrial ND1 gene in human colorectal cancer. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. 2011;16(1):50-5.
Theodoratou E, Din FV, Farrington SM, Cetnarskyj R, Barnetson RA, Porteous ME, et al. Association between common mtDNA variants and all-cause or colorectal cancer mortality. Carcinogenesis. 2010;31(2):296-301.
Guo Z, Zhao S, Fan H, Du Y, Zhao Y, Wang G. Identification of sequence polymorphisms in the D-Loop region of mitochondrial DNA as a risk factor for colon cancer. Mitochondrial DNA Part A, DNA mapping, sequencing, and analysis. 2016;27(6):4244-5.
Wallace L, Mehrabi S, Bacanamwo M, Yao X, Aikhionbare FO. Expression of mitochondrial genes MT-ND1, MT-ND6, MT-CYB, MT-COI, MT-ATP6, and 12S/MT-RNR1 in colorectal adenopolyps. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016;37(9):12465-75.
Govatati S, Saradamma B, Malempati S, Dasi D, Thupurani MK, Nagesh N, et al. Association of mitochondrial displacement loop polymorphisms with risk of colorectal cancer in south Indian population. Mitochondrial DNA Part A, DNA mapping, sequencing, and analysis. 2017;28(5):632-7.
Thyagarajan B, Guan W, Fedirko V, Barcelo H, Ramasubramaian R, Gross M, et al. Associations of mitochondrial polymorphisms with sporadic colorectal adenoma. Molecular carcinogenesis. 2018;57(5):598-605.
Horton TM, Petros JA, Heddi A, Shoffner J, Kaufman AE, Graham SD, Jr., et al. Novel mitochondrial DNA deletion found in a renal cell carcinoma. Genes, chromosomes & cancer. 1996;15(2):95-101.
Xu J, Guo Z, Zhang J, Cui L, Zhang S, Bai Y. Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of renal cell carcinoma. Sci Rep. 2013;3:2408.
Zhang J, Guo Z, Bai Y, Cui L, Zhang S, Xu J. Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for renal cell carcinoma. Biomedical reports. 2013;1(4):563-6.
Bai Y, Guo Z, Xu J, Liu S, Zhang J, Cui L, et al. Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with renal cell carcinoma outcome. Mitochondrial DNA. 2015;26(2):224-6.
Bai Y, Guo Z, Xu J, Zhang J, Cui L, Zhang H, et al. The 9-bp deletion at position 8272 in region V of mitochondrial DNA is associated with renal cell carcinoma outcome. Mitochondrial DNA Part A, DNA mapping, sequencing, and analysis. 2016;27(3):1973-5.
Purdue MP, Hofmann JN, Colt JS, Hoxha M, Ruterbusch JJ, Davis FG, et al. A case-control study of peripheral blood mitochondrial DNA copy number and risk of renal cell carcinoma. PloS one. 2012;7(8):e43149.
Hofmann JN, Hosgood HD, 3rd, Liu CS, Chow WH, Shuch B, Cheng WL, et al. A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Carcinogenesis. 2014;35(5):1028-31.
- Abstract Viewed: 158 times
- PDF Downloaded: 99 times